New Abu Dhabi clinical trials using AI to have ‘massive’ impact on health care

The National · 2h ago

Oracle expects its new artificial intelligence partnership with AstraZeneca and Abu Dhabi’s M42 to have a “massive impact” on the region’s healthcare systems by cutting the time and cost of running clinical trials , according to a senior executive at the tech firm. Under the collaboration announced last week, AstraZeneca will pair its scientific development with Oracle’s cloud infrastructure and…

Read original article on The National →

New Abu Dhabi clinical trials using AI to have ‘massive’ impact on health care

Related news